Wells Fargo’s Takeda Pharmaceutical TAK Stock Holding History

Wells Fargo’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-35,000	Closed	-$477K	–	7786
2021 Q4	$477K	Hold	35,000	–	–	﹤0.01%	4702
2021 Q3	$573K	Sell	35,000 -2,000	-5%	-$33.6K	﹤0.01%	4590
2021 Q2	$623K	Hold	37,000	–	–	﹤0.01%	4502
2021 Q1	$676K	Buy	+37,000	New	+$666K	﹤0.01%	4512

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Wells Fargo's TAK Position: Q2 2026 in Review

Wells Fargo increased its Takeda Pharmaceutical (TAK) stake by 1.3% in Q2 2026, buying an estimated $245K and bringing the position to 1,150,820 shares worth $18.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

Wells Fargo first reported a position in TAK in Q4 2018 and has held it in 31 quarters since. The position peaked at $46M in Q1 2021. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Wells Fargo held 1,150,820 shares of Takeda Pharmaceutical worth $18.4M as of Q2 2026.
Wells Fargo bought 14,798 Takeda Pharmaceutical shares in Q2 2026, an estimated $245K.
Takeda Pharmaceutical made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1708 holding.
Wells Fargo first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 31 quarters since.
Wells Fargo's Takeda Pharmaceutical position peaked at $46M in Q1 2021.
379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.